Position in VTRS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$624,932
+$224,203 QoQ
Shares Held
46,257
+22.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
3 quarters on record
Voting authority
Sole 54.48040296603758.ToString("F0")%
Shared 0.ToString("F0")%
None 45.51959703396243.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $41,938,404 across 7 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
293,996 | $22,608,292 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
55,055 | $7,252,945 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,240,692 | $7,196,013 | |
| 4 | HROW |
Harrow, Inc.
|
74,256 | $2,618,266 | |
| 5 | ZTS |
Zoetis Inc.
|
8,496 | $1,004,312 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
50,977 | $633,644 | |
| 7 | VTRS |
Viatris Inc
This page
|
46,257 | $624,932 |
All Filings in VTRS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $624,932 | 46,257 | Shares | Sole | 2026-05-13 | |
| 2024-06-30 | $400,729 | 37,698 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $377,256 | 31,596 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||